Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.064 | 0.7 |
mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.7 |
mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |